Sexually Transmitted Diseases (STD) Testing Market to Reach $150.44 Billion, Globally, by 2030 at 5.1% CAGR: AMR

High prevalence and rise in incidences of STD and implementation of national screening programs have boosted the growth of the global sexually transmitted diseases (STD) testing market

PORTLAND, Ore., Jan. 13, 2022 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Sexually Transmitted Diseases (STD) Testing Market by Disease Type (Chlamydia, Gonorrhea, Herpes Simplex Virus, Syphilis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), and Other Diseases) and Location of Testing (Laboratory Testing, and Point-of-care (POC) Testing): Global Opportunity Analysis and Industry Forecast, 2021-2030". As per the report, the global sexually transmitted diseases (STD) testing industry was accounted for $91.44 billion in 2030, and is expected to garner $150.44 billion by 2030, registering at a CAGR of 5.1% from 2021 to 2030.

For Right Perspective and Competitive Insights, Get Sample Report at:

https://www.alliedmarketresearch.com/request-sample/385

Drivers, restraints, and opportunities

High prevalence and rise in incidences of STDs, supporting reimbursement for STDs testing, and implementation of national screening programs have boosted the growth of the global sexually transmitted diseases (STD) testing market. However, huge proportion of patients infected with STDs in remote areas, stringent regulatory abidance requirements for the participants of the STD market, huge number of patients infected with STDs in remote areas, and social stigma associated with patients visiting specialized STD clinics hinder the market growth. On the contrary, reduction in the number of visits to government clinics, national screening programs, and advancements in technology and POC tests are expected to open new opportunities in the future.

Covid-19 scenario:

• The Covid-19 pandemic had a negative impact on the STD testing market due to decline in number of STD cases and disruptions in the healthcare sector.
• During the pandemic, the non-urgent visits and preventive services were reduced to preserve personal protective equipment supply.

The gonorrhea segment to manifest the highest through 2030

By disease type, the gonorrhea segment is expected to manifest the highest CAGR of 7.3% during the forecast period. However, the chlamydia testing segment dominated the market in 2020, accounting for more than one-fourth of the market, due to lack of awareness about sexually transmitted diseases among population and lack of barrier protection.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/385

The laboratory testing segment dominated the market

By location of testing, the laboratory testing segment held the lion's share in 2020, contributing to more than four-fifths of the market, as most of the cases of diagnostic testing are carried out in the labs. However, the point of care testing segment is anticipated to register the highest CAGR of 6.3% from 2021 to 2030, due to untapped markets in developing countries.

Asia-Pacific, followed by LAMEA and North America, held the lion's share

By region, Asia-Pacific, followed by LAMEA and North America, dominated the market in 2020, contributing to more than half of the market. Moreover, the region is expected to portray the highest CAGR of 5.3% during the forecast period, owing to increase in case of sexual transmitted diseases in emerging countries and rise in patient awareness through education campaigns.

Major market players

• Abbott laboratories
• BioMérieux, Inc.
• Becton Dickinson Company
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• Hologic, Inc.
• Diasorin Molecular LLC
• Roche Holding AG
• Orasure Technologies, Inc.,
• Thermo Fisher Scientific Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

HIV Drugs Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Minimally Invasive Surgical Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Surgical Robots Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Medical Spa Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Orthodontics Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo